Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick W Sullivan

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Journal of Managed Care & Specialty Pharmacy|September 26, 2025
Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetesJun Wu, Alexandra Perez, Patrick W Sullivan
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 5, 2017
Estimating asthma control questionnaire (ACQ) scores from claims dataPatrick W Sullivan, Vahram H Ghushchyan, Gary Globe
Medical Care|June 23, 2005
A national catalog of preference-based scores for chronic conditions in the United StatesPatrick W Sullivan, William F Lawrence, Vahram Ghushchyan
Obesity (Silver Spring, Md.)|February 3, 2009
The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United StatesPatrick W Sullivan, Vahram Ghushchyan, Rami H Ben-Joseph
Current Medical Research and Opinion|September 11, 2010
Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITERJulia F Slejko, Robert L Page, Patrick W Sullivan
Pharmacoeconomics|September 15, 2004
Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitisPatrick W Sullivan, Sheryl L Follin, Michael B Nichol
The American Journal of Managed Care|June 25, 2005
The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapyPatrick W Sullivan, Kavita V Nair, Bimal V Patel
Medical Care|December 12, 2003
Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysisPatrick W Sullivan, Sheryl L Follin, Michael B Nichol
Pharmacoeconomics|March 29, 2012
The impact of co-morbidity burden on preference-based health-related quality of life in the United StatesPatrick W Sullivan, Vahram H Ghushchyan, Elizabeth A Bayliss
Current Medical Research and Opinion|April 14, 2010
The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitisPatrick W Sullivan, Prakash Navaratnam, Richard Lorber, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Journal of Managed Care & Specialty Pharmacy|September 26, 2025
Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetesJun Wu, Alexandra Perez, Patrick W Sullivan
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 5, 2017
Estimating asthma control questionnaire (ACQ) scores from claims dataPatrick W Sullivan, Vahram H Ghushchyan, Gary Globe
Medical Care|June 23, 2005
A national catalog of preference-based scores for chronic conditions in the United StatesPatrick W Sullivan, William F Lawrence, Vahram Ghushchyan
Obesity (Silver Spring, Md.)|February 3, 2009
The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United StatesPatrick W Sullivan, Vahram Ghushchyan, Rami H Ben-Joseph
Current Medical Research and Opinion|September 11, 2010
Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITERJulia F Slejko, Robert L Page, Patrick W Sullivan
Pharmacoeconomics|September 15, 2004
Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitisPatrick W Sullivan, Sheryl L Follin, Michael B Nichol
The American Journal of Managed Care|June 25, 2005
The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapyPatrick W Sullivan, Kavita V Nair, Bimal V Patel
Medical Care|December 12, 2003
Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysisPatrick W Sullivan, Sheryl L Follin, Michael B Nichol
Pharmacoeconomics|March 29, 2012
The impact of co-morbidity burden on preference-based health-related quality of life in the United StatesPatrick W Sullivan, Vahram H Ghushchyan, Elizabeth A Bayliss
Current Medical Research and Opinion|April 14, 2010
The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitisPatrick W Sullivan, Prakash Navaratnam, Richard Lorber, et al.
Pageof 7